EW Forecast + Trading Strategies


Bullish Case: Edwards Lifesciences' innovations in TAVR technology and recent acquisitions, combined with stabilizing volatility, can drive revenue growth.


Bearish Case: The EU antitrust investigation and competitive pressures could harm revenue and market sentiment, aggravated by flat volatility and recent flat stock performance.


Potential Outcomes: 45%: Innovation-driven growth. 35%: Regulatory and competitive pressures hamper growth. 15%: Market uncertainty impacts stock. 5%: Acquisitions speed up growth.


Trading Oracle: Sign Up to access trading oracle trade ideas.


July 14, 2024


Edwards Lifesciences Forecast

EW      Edwards Lifesciences











Correlated Assets

Assets that tend to move strongly with EW



ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (0.8)


XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (0.57)


LI Forecast + Options Trading Strategies   LI  Li Auto (-0.52)


VFC Forecast + Options Trading Strategies   VFC  VF (-0.54)



Uncorrelated Assets

Assets with little price relationship to EW



LI Forecast + Options Trading Strategies   LI  Li Auto (-0.52)


VFC Forecast + Options Trading Strategies   VFC  VF (-0.54)


XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (0.57)


ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (0.8)



Anticorrelated Assets

Assets that tend to move strongly against EW



ETRN Forecast + Options Trading Strategies   ETRN  Equitrans Midstream (0.8)


XLE Forecast + Options Trading Strategies   XLE  Energy Select Sector SPDR (0.57)


LI Forecast + Options Trading Strategies   LI  Li Auto (-0.52)


VFC Forecast + Options Trading Strategies   VFC  VF (-0.54)





Become a more profitable investor with AI optimized trading strategies






×

Chat with EW


 Ask any question about EW!